文献速递慢阻肺

CEACAM6作为增强COPD中HO-1介导抗氧化防御的新治疗靶点

CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

本研究探讨对烟草烟雾不敏感的吸烟者防御亚硝化/氧化应激的机制。通过四个队列样本及体外构建的香烟烟雾提取物抵抗细胞系,发现3-NT水平与COPD严重程度相关,CEACAM6负调控肺泡2型上皮细胞中HO-1介导的防御,其过表达增加应激和细胞死亡。结论提示CEACAM6表达决定易感吸烟者肺气肿发展的敏感性。

要点

  • 3-NT水平与COPD患者疾病严重程度相关。
  • CEACAM6负调控hAEC2s中HO-1介导的亚硝化/氧化应激防御。
  • 上皮特异性CEACAM6过表达增加CSE处理后的应激和细胞死亡。

核心结论

  • CEACAM6表达决定hAEC2对亚硝化/氧化应激的敏感性,从而影响易感吸烟者肺气肿的发生/进展。

研究设计与样本

  • 研究纳入四个队列:痰样本(健康n=4;COPD n=37)、肺组织样本(健康n=13;无COPD吸烟者n=10;吸烟者+COPD n=17)、肺叶切除组织样本(无/轻度肺气肿n=6)、血液样本(健康n=6;COPD n=18)。
  • 建立香烟烟雾提取物(CSE)抵抗细胞系的体外模型,研究3-NT形成、抗氧化能力和转录组谱。
  • 结果在肺组织、分离的原代细胞以及使用腺相关病毒介导的基因转导和人精密切割肺切片的离体模型中验证。

主要发现

  • 3-NT水平与患者COPD严重程度相关。
  • 在CSE抵抗细胞中,CSE处理后的亚硝化/氧化应激减弱,伴随血红素加氧酶-1(HO-1)的显著上调。
  • 鉴定出癌胚抗原细胞黏附分子6(CEACAM6)作为人肺泡2型上皮细胞(hAEC2s)中HO-1介导的亚硝化/氧化应激防御的负调控因子。
  • 抑制hAEC2s中HO-1活性增加对CSE诱导损伤的易感性。
  • 上皮特异性CEACAM6过表达增加人精密切割肺切片在CSE处理后的亚硝化/氧化应激和细胞死亡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Tobacco smoking and air pollution are primary causes of chronic obstructive pulmonary disease (COPD). However, only a minority of smokers develop COPD. The mechanisms underlying the defense against nitrosative/oxidative stress in nonsusceptible smokers to COPD remain largely unresolved. Objectives: To investigate the defense mechanisms against nitrosative/oxidative stress that possibly prevent COPD development or progression. Methods: Four cohorts were investigated: 1) sputum samples (healthy, n = 4; COPD, n = 37), 2) lung tissue samples (healthy, n = 13; smokers without COPD, n = 10; smoker+COPD, n = 17), 3) pulmonary lobectomy tissue samples (no/mild emphysema, n = 6), and 4) blood samples (healthy, n = 6; COPD, n = 18). We screened 3-nitrotyrosine (3-NT) levels, as indication of nitrosative/oxidative stress, in human samples. We established a novel in vitro model of a cigarette smoke extract (CSE)-resistant cell line and studied 3-NT formation, antioxidant capacity, and transcriptomic profiles. Results were validated in lung tissue, isolated primary cells, and an ex vivo model using adeno-associated virus-mediated gene transduction and human precision-cut lung slices. Measurements and Main Results: 3-NT levels correlate with COPD severity of patients. In CSE-resistant cells, nitrosative/oxidative stress upon CSE treatment was attenuated, paralleled by profound upregulation of heme oxygenase-1 (HO-1). We identified carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) as a negative regulator of HO-1-mediated nitrosative/oxidative stress defense in human alveolar type 2 epithelial cells (hAEC2s). Consistently, inhibition of HO-1 activity in hAEC2s increased the susceptibility toward CSE-induced damage. Epithelium-specific CEACAM6 overexpression increased nitrosative/oxidative stress and cell death in human precision-cut lung slices on CSE treatment. Conclusions: CEACAM6 expression determines the hAEC2 sensitivity to nitrosative/oxidative stress triggering emphysema development/progression in susceptible smokers.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Wu CY, Cilic A, Pak O, et al. CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD. Am J Respir Crit Care Med. 2023. PMID: 37219322. doi:10.1164/rccm.202208-1603OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。